Seqens, a developer and producer of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, has named Pascal Villemagne as Chief Executive Officer, effective April 1, 2025. Villemagne brings a wealth of experience to the role, having previously served as CEO of Carbogen Amcis, a company specializing in the manufacture and development of custom APIs, where he was instrumental in the transformation of the company, successfully leading structural changes and s...